A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer

Clinical trial NCT01300533 · COMPLETED

Trial details

NCT number: NCT01300533
Sponsor: BIND Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Cancer Cancer Solid Tumors

Start date: 2011-01-01
Primary completion: 2013-09-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.